Market Access Success in Small Biotech | Ray Frost | Ep. 9 Ray Frost shares 20 years of market access expertise, revealing how small biotechs can successfully launch drugs in today's complex US healthcare landscape. In this episode of BioPharma Unscripted with Marcus Metcalfe, market access veteran Ray Frost discusses building commercial infrastructure from scratch, the critical timing for market access involvement, and why the HEOR partnership is "absolutely critical" for launch success. K...
From Forests to Pharma: Rasmus Jensen on Cultural Intelligence and Career Transformation - Ep. 8 Join Marcus Metcalfe as he sits down with Rasmus Jensen for a captivating conversation about one of the most unconventional career journeys in pharma. Starting with ambitions to become a forest ranger, complete with chainsaw training. Rasmus shares how he transformed his forestry economics background into a successful pharmaceutical career spanning global corporations and dynamic startups. In th...
Value-Based Healthcare: Lessons from a HEOR Expert | BioPharma Unscripted! Ep.7 Join Marcus Metcalfe as he speaks with Colette Mankowski, a veteran in Health Economics, Outcomes Research & Market Access with over 25 years of industry experience. In this candid conversation, Colette shares her unconventional journey into health economics, her career trajectory at Astellas, and her transition to independent consulting and mindfulness coaching. Colette explains how she rose from medical in...
Building Successful Market Access Strategies from Day One - BioPharma Unscripted Ep. 6 In this episode of BioPharma Unscripted!, host Marcus speaks with pharmaceutical market access expert Ana Filipa Alexandre, PharmD, MPH about the critical importance of early access planning in drug development. Ana shares insights from her extensive career spanning regulatory affairs, health economics, and market access, explaining why companies must consider access strategies from the earliest stages of d...
Regulatory Expertise for Early-Stage Biotechs | BioPharma Unscripted! Ep.5 Join Marcus Metcalfe in conversation with Ming Ewe as they explore the critical role of regulatory expertise in early-stage biotech companies and advanced therapy development. In this insightful discussion, Ming shares her extensive experience as a regulatory mentor for biotech startups, explaining why engaging regulatory professionals early can prevent costly mistakes and streamline development pathways. She highlig...
Performance Communications in a Digital World | BioPharma Unscripted! Ep.4 Join Marcus Metcalfe in conversation with Jens Christmann as they explore the evolving world of corporate communications and digital transformation in the life sciences sector. In this engaging discussion, Jens shares insights from his journey transitioning from the FMCG world at Mars to leading digital transformation at Mundipharma , and now to establishing his own interim management and consulting practice. He explai...
Navigating the Freelance Path in Life Sciences | BioPharma Unscripted! Ep.3 Join Marcus Metcalfe in conversation with Hannah Kurth as they explore the rewarding yet challenging world of freelance consulting in the life sciences sector. In this candid discussion, Hannah shares her journey into freelance consulting after over two decades of experience across pharmaceutical, biotech, and medical device companies. Having recently launched her own consultancy, she offers fresh insights into the d...
The Power of Interim Talent: Strategic Healthcare Expertise | BioPharma Unscripted! Ep.2 Join Marcus Metcalfe as he speaks with Andrew Xia about using interim consultants in the life sciences sector. In this insightful conversation, Andrew shares his perspective as an experienced interim consultant specialising in health economics, market access, and real-world evidence. He explains why clients and consultants find the interim model beneficial, addressing common misconceptions and highlightin...
European Market Access Strategy: Navigating the Joint Clinical Assessment | Elucid8 Podcast Ep.1 Join Marcus Metcalfe speaking with Martin Gisby about European market access and the upcoming Joint Clinical Assessment (JCA) launching January 2025. Martin explains successful market access strategies in Europe, emphasising demonstrating comparative effectiveness versus standard of care. He offers practical guidance on the changing regulatory landscape for pharmaceutical companies planning Europe...